Pfizer Financials
| PFE Stock | 12.12 0.03 0.25% |
Pfizer |
| Foreign Associates | |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | Canada Stock View All |
| Exchange | NEO Exchange |
| ISIN | CA7170651060 |
| Business Address | 66 Hudson Boulevard |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.pfizer.com |
| Phone | 212 733 2323 |
You should never invest in Pfizer without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Pfizer Stock, because this is throwing your money away. Analyzing the key information contained in Pfizer's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Pfizer Key Financial Ratios
Pfizer's financial ratios allow both analysts and investors to convert raw data from Pfizer's financial statements into concise, actionable information that can be used to evaluate the performance of Pfizer over time and compare it to other companies across industries.| Return On Equity | 0.0906 | ||||
| Return On Asset | 0.0464 | ||||
| Beta | 0.54 | ||||
| Last Dividend Paid | 1.68 |
Pfizer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pfizer's current stock value. Our valuation model uses many indicators to compare Pfizer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pfizer competition to find correlations between indicators driving Pfizer's intrinsic value. More Info.Pfizer Inc CDR is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pfizer Inc CDR is roughly 1.95 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pfizer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pfizer's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Pfizer Inc CDR Systematic Risk
Pfizer's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pfizer volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Pfizer Inc CDR correlated with the market. If Beta is less than 0 Pfizer generally moves in the opposite direction as compared to the market. If Pfizer Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pfizer Inc CDR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pfizer is generally in the same direction as the market. If Beta > 1 Pfizer moves generally in the same direction as, but more than the movement of the benchmark.
Pfizer Thematic Clasifications
Pfizer Inc CDR is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Healthcare | View |
Pfizer March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pfizer help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pfizer Inc CDR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pfizer Inc CDR based on widely used predictive technical indicators. In general, we focus on analyzing Pfizer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pfizer's daily price indicators and compare them against related drivers.
| Information Ratio | 0.045 | |||
| Maximum Drawdown | 5.26 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 1.59 |
Other Information on Investing in Pfizer Stock
Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.